Flor M. Muñoz, MD, MSc, is an associate professor of pediatrics, infectious diseases, molecular virology and microbiology at Baylor College of Medicine and Texas Children’s Hospital in Houston, TX. She is a physician-scientist with research activities focusing on the evaluation of vaccine safety and efficacy in special populations including pregnant women, children, and people with compromised immune systems, as well as the epidemiology and treatment of respiratory pathogens such as RSV, influenza, SARS-CoV2, and pertussis.

Dr. Muñoz actively participates in various national and international committees and research networks including the American Academy of Pediatricians Section of Infectious Diseases (SOID) (Chair elect),the American College of Obstetrics and Gynecology (ACOG) Immunization Expert Group, the Infectious Diseases Society of America, the Committee for Research of the European Society of Infectious Diseases (ESPID), the Latin American Society of Pediatric Infectious Diseases (SLIPE), the CDC National Vaccine Surveillance Network (NVSN), the Global Vaccine Data Network (GVDN) project, and the Coalition for Epidemic Preparedness Innovations (CEPI)- Safety Platform for Emergency vACcines (SPEAC)-Brighton Collaboration project where she leads the Special Populations work group. Dr. Munoz is Chair of the institutional review board at Baylor College of Medicine. She is a member of the Board of Directors of the National Foundation of Infectious Diseases (NFID) and of the FDA VRBPAC. She contributes to projects supported by private and public organizations, including the World Health Organization to address infectious disease prevention to improve the health of women and children worldwide.